Innovative Pharma
A Russian industry association of research-based pharmaceutical companies that coordinates member activities, represents industry positions to government and regulators, develops normative recommendations for pharmaceutical communications and quality, organises national, regional and virtual conferences and training, and convenes expert working groups on regulatory, market access and biotechnology policy. The association promotes international cooperation and supports dialogue on pricing, reimbursement, manufacturing quality, digital health, telemedicine, real‑world data and AI.
Industries
N/A
Nr. of Employees
small (1-50)
Services
Organises sector conferences, forums, summits and hybrid/online workshops on biotechnology, GMP/GXP, regulatory practice, market access, digital health, telemedicine and related topics.
Represents member interests to authorities and participates in policy dialogue and expert councils on pricing, reimbursement, IP, regulatory reform and EAEU harmonisation.
Maintains a membership directory and market participant maps to improve transparency and support partner discovery and collaboration.
Organises trainings and practical sessions on EAEU registration, dossier preparation, GCP/GMP basics and pharmacovigilance for industry and regulators.
Develops recommendations and self‑regulatory documents on advertising and promotional communications for the pharmaceutical sector.
Organises sector conferences, forums, summits and hybrid/online workshops on biotechnology, GMP/GXP, regulatory practice, market access, digital health, telemedicine and related topics.
Represents member interests to authorities and participates in policy dialogue and expert councils on pricing, reimbursement, IP, regulatory reform and EAEU harmonisation.
Maintains a membership directory and market participant maps to improve transparency and support partner discovery and collaboration.
Organises trainings and practical sessions on EAEU registration, dossier preparation, GCP/GMP basics and pharmacovigilance for industry and regulators.
Develops recommendations and self‑regulatory documents on advertising and promotional communications for the pharmaceutical sector.
Expertise Areas
- Regulatory policy and government affairs
- Market access, pricing and reimbursement
- Clinical and regulatory training (GCP/GMP/pharmacovigilance)
- Biotechnology and medtech industry development
Key Technologies
- Artificial intelligence and big data analytics
- Real‑world data (RWD) and real‑world evidence (RWE)
- Digital health platforms and telemedicine
- Bioinformatics
News & Updates
Annual forum on biotechnology, pharmaceutical manufacturing and health policy for government officials, industry and research institutions.
Conference focused on innovation in pharmaceutical and medical industries, including topics such as personalized medicine, radionuclide drugs, pharma engineering, digitalisation and regulatory harmonisation.
Event presenting opportunities of an international medical cluster for business development in regenerative and cell technologies, telemedicine and bioinformatics, with participation invited from industry representatives.
Report on a regional forum gathering federal and regional health officials, industry representatives and innovators to discuss healthcare strategy, laboratory medicine, oncology programmes and digital health.
Announcement of a two‑day training on EAEU registration rules, clinical and preclinical documentation requirements, and regional dossier formats.
Annual forum on biotechnology, pharmaceutical manufacturing and health policy for government officials, industry and research institutions.
Conference focused on innovation in pharmaceutical and medical industries, including topics such as personalized medicine, radionuclide drugs, pharma engineering, digitalisation and regulatory harmonisation.
Event presenting opportunities of an international medical cluster for business development in regenerative and cell technologies, telemedicine and bioinformatics, with participation invited from industry representatives.
Report on a regional forum gathering federal and regional health officials, industry representatives and innovators to discuss healthcare strategy, laboratory medicine, oncology programmes and digital health.
Announcement of a two‑day training on EAEU registration rules, clinical and preclinical documentation requirements, and regional dossier formats.